| The Lung EArly Proteins (LEAP) Project |
Hilary Robbins |
International Agency for Research on Cancer |
PLCO |
Feb 3, 2022 |
2021-1022 |
| Competing risks analysis of multiple cancers with application to vitamin D in PLCO |
Yei Eun Shin |
Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute |
PLCO |
Feb 2, 2022 |
PLCO-904 |
| Development of a ML algorithm to predict ovarian cancer risk |
Nicolas Martelin |
Prostperia SAS |
PLCO |
Jan 27, 2022 |
PLCO-903 |
| Lung Cancer Patient's survival analysis |
Sreekanth Settur |
Swiss School of Business and Management |
PLCO |
Jan 27, 2022 |
PLCO-902 |
| Pan-cancer gene-environment interaction studies |
jianbo Tian |
School of Health Public Wuhan University |
PLCO |
Jan 18, 2022 |
PLCO-900 |
| BMI and the risk of renal cell carcinoma : a case control study |
Benjamin Chung |
Stanford University |
PLCO |
Jan 18, 2022 |
PLCO-896 |
| Interpretable AI prediction of prostate tumor staging |
Matthias Weidemüller |
Universität Heidelberg |
PLCO |
Jan 18, 2022 |
PLCO-897 |
| Association of dietary carrot intake with colorectal cancer incidence and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial |
zongze Jiang |
West China Fourth Hospital |
PLCO |
Jan 18, 2022 |
PLCO-899 |
| The influence of biological factors and environmental exposure on the occurrence and prognosis of various cancers and the construction of prediction models |
Xiaorong Yang |
Qilu Hospital of Shandong University |
PLCO |
Jan 13, 2022 |
PLCO-890 |
| Development and evaluation of combined cancer screening strategies for high-risk populations of Prostate, Lung, Colorectal and Ovarian Cancers |
Huang Yubei |
Tianjin Medical University Cancer Institute and Hospital |
PLCO |
Jan 13, 2022 |
PLCO-895 |
| Threshold quantile regression models with applications to PSA data |
Eun Ryung Lee |
Sungkyunkwan University |
PLCO |
Jan 7, 2022 |
PLCO-893 |
| Modeling risk for lung cancer using trans-ancestry polygenic risk score, blood biomarkers, and lifestyle behaviors |
Meng Zhu |
Nanjing Medical University |
PLCO |
Jan 7, 2022 |
PLCO-892 |
| The timing between the diagnosis and the end of the last treatment in the cancer continuum in patients with colon cancer by TNM stages; and the impact of delays in the final survival of the patients, in PLCO, In the period available in the data set. |
Percy Guzman |
Percy Guzman |
PLCO |
Jan 7, 2022 |
PLCO-882 |
| Evaluating key determinants for the risk of second primary lung cancer among bladder cancer survivors using population-based screening trial data from the PLCO |
Summer Han |
Stanford University |
PLCO |
Jan 5, 2022 |
PLCO-886 |
| The impact of hormone replacement therapy on cancer |
Zhaoyu Li |
University of Western Australia |
PLCO |
Dec 30, 2021 |
PLCO-883 |
| Meta-analysis of 16S head and neck cancer |
Kenny Yeo |
University of Adelaide |
PLCO |
Dec 14, 2021 |
PLCO-879 |
| Detection of prostate cancer using machine learning techniques: An exploratory study |
Laxmi Manasa Gorugantu |
Dakota State University |
PLCO |
Dec 13, 2021 |
PLCO-873 |
| Reproducibility and external validation of epidemiological risk models for endometrial cancer |
Aline Talhouk |
Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, Canada |
PLCO |
Dec 13, 2021 |
PLCO-878 |
| Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO |
Hormuzd Katki |
NCI |
PLCO |
Dec 8, 2021 |
PLCO-875 |
| Using PRS for CRC screening |
Ulrike Peters |
Fred Hutchinson Cancer Research Center |
PLCO |
Dec 8, 2021 |
PLCO-872 |
